The cornea is a transparent organ with well-defined anatomic features. Its clarity is sustained throughout life through the metabolic activity of epithelial cells, keratocytes and mitotically inactive endothelial cells. Loss of cell function, whether through inherited defects, trauma or age, results in a loss of corneal transparency and vision ( Figure 1 ). Although adenoviral vectors are able to introduce foreign genes into corneal endothelial cells, transgene expression is short lived.
1-4 Similar short-term expression has been observed with electropulse-mediated gene delivery to rat endothelial cells 5 and liposomemediated transfection of human keratocytes. 6 Lentiviral vectors are integrating vectors with a broad tropic range, able to transduce mitotically active or inactive cells, making them potentially useful for the transfer of genetic information into all corneal cell types. Lentiviruses possess nuclear localization signals that permit nuclear import of the viral preintegration complex. 7, 8 A lentivirus-based vector, pseudotyped with the vesicular stomatitis virus G glycoprotein (VSV-G), permits the virion to enter host cells via nonspecific binding to mem-tocytes were transduced at an MOI of 1000. The proportion of eGFP-positive cells remained unchanged throughout continuous culture for 60 days, indicating stable expression and a lack of selective pressure for or against transduced cells. Human corneal tissue, obtained at the time of penetrating keratoplasty, demonstrated efficient in situ transduction with this vector. Endothelial cells, epithelial cells and stromal keratocytes at the exposed cut edge of the corneal tissue in situ demonstrated eGFP expression. Underlying stromal cells not in direct contact with vector-containing media, were not transduced, implying that virus-cell contact is required for transduction. Transduced corneal tissues expressed eGFP in situ for the life of the corneal button in extended organ culture (60 days). These results imply that lentiviral vectors may prove to be useful tools, able to transduce corneal tissue efficiently, and that transgene expression is temporally stable. Gene Therapy (2000) 7, 196-200.
brane phospholipids and also decreases fragility of the virus thereby permitting concentration of viral particles by ultracentrifugation. 9, 10 The lentiviral vector pseudotyped with VSV-glycoprotein has a broad target cell range allowing the vector to transduce a diversity of cells, such as human hematopoietic stem cells, 11, 12 rat hippocampal cells, 13, 14 human macrophages, 15 rat liver and muscle cells, 16 and rat retinal cells. 17 Unlike other transplanted tissues, the cornea can be maintained in vitro for days, 18, 19 allowing ex vivo transduction before transplantation. 3 The permanent genetic modification of corneal cells may benefit patients with a wide variety of corneal defects. Approximately 50% of corneal allografts are undertaken as a consequence of primary endothelial dysfunction. 20, 21 Immune responses against the endothelial cells of transplanted corneas often results in rejection of the allograft. 22 The stable incorporation of genes known to modify allograft rejection may prove a useful addition to current treatment protocols. In this study we examine the ability of a lentiviral vector to transduce human corneal cells in vitro and tissue in situ.
Recombinant lentiviruses were produced as described by Naldini et al. 14 The cytomegalovirus (CMV) immediate-early gene promoter directed expression of eGFP in the plasmid pHR′-CMV-eGFP. Stocks of virus were generated as follows. Human kidney 293T cells (5 × 10 6 ) were plated on 10-cm plates, and were cotransfected the fol- lowing day with 10 g of pCMV⌬R8.91 (packaging function plasmid), 10 g of pHR′-CMV-eGFP (marker gene plasmid), and 2 g of pMD.G (the VSV-G envelope containing plasmid) by calcium phosphate precipitation in D10 growth medium (high glucose DMEM with 10% fetal bovine serum (FBS, Irvine Scientific, CA, USA)) and antibiotics (Fungi-Bact solution; Irvine Scientific). After 12-16 h at 37°C, the medium was removed and fresh D10 growth medium was added. Cells were cultured for an additional 10 h. Fresh D10, containing 10 mm sodium butyrate (Sigma, St Louis, MO, USA) and 20 mm Hepes buffer was added to the cells and the cells were cultured for another 12 h. This medium was replaced with new D10 medium containing 20 mm Hepes buffer, and after 12 h the virus-containing medium was collected. Fresh medium was added and the supernatant was collected every 24 h for the following 4 days. The viral supernatant was stored at −80°C immediately after collection. Viral stocks were concentrated by ultracentrifugation of the supernatant (19 000 r.p.m., Beckman SW28 rotor) for 140 min at room temperature and the resulting viral pellets were resuspended in 1-3 ml of phosphate-buffered saline (PBS; Irvine Scientific). Aliquoted viral stocks were titered with 293 cells (American Type Culture Collection (ATCC), Rockville, MD, USA) and the remaining samples were stored at −80°C. All lentiviral vector supernatants were assayed for the presence of replication-competent retrovirus (RCR) by infection of phytohemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells, with subsequent analysis of the culture medium for p24 gag by ELISA (Coulter, Hialeah, FL, USA), after 2
Gene Therapy weeks of culture. RCR was not detected in any of the viral supernatants produced.
Transduction efficiency was measured as a function of multiplicity of infection with MOIs ranging from 1 to 1000. There is a positive correlation between MOI and transduction efficiency. Maximum gene transfer was obtained with an MOI of 1000 resulting in over 90% of cells expressing eGFP (Figure 2) . No obvious detrimental effects to the cells, either at the morphologic level or by alterations in growth index, were observed after addition of the virus, even at the higher concentrations of virus. To determine the duration of eGFP transgene expression in keratocytes, cells were tested over a period of 60 days after the initial transduction event. Ninety-two per cent of cells were positive for eGFP 1 week after transduction with the lentiviral-eGFP constructs. Over 90% of the cells remained positive for eGFP at 20, 40 and 60 posttransduction days. Thus, stable expression of the transgene was noted and selective pressure for or against transduced cells was not apparent (Figure 3) .
A total of five fresh corneal rims or corneal buttons were tested for efficient lentivirus-mediated eGFP gene transfer into all cell types of the cornea. Fluorescent microscopy reveals eGFP expression in endothelial (Figure 4a ) and epithelial cells ( Figure 5 ) by 3 posttransduction days in situ. This pattern of expression was undiminished for the duration of organ culture (60 days). Endothelial cells, attached to Descemet's membrane, were peeled away from the transduced corneal tissue, and examined by light (Figure 4b ) and fluorescent microscopy ( Figure 4c ). The corneal endothelium was positive for eGFP, indicating that efficient gene transfer and expression were attained.
Anatomic Gift Foundation). Eyes were bisected 2-3 mm posterior to the limbus. The corneoscleral button was washed with Hank's buffered saline solution (HBSS; Irvine Scientific) and the remaining sclera and Descemet's membrane, with attached endothelial cells, were removed. The button containing the epithelial and stromal layers were incubated in HBSS containing 2% dispase (GibcoBRL, Gaithersburg, MD, USA) at 37°C for 50 min. Corneal epithelial cells were removed with a sterile inoculating loop. The corneal stromal layer was minced and cultured in DMEM, containing 15% FBS for 10 days. Primary keratocytes were harvested and grown in DMEM with 10% FBS (D10). All cells were tested before the fifth passage. Primary keratocytes, cultured in six-well plates, were exposed to varying numbers of viral particles; MOIs of 1, 10, 100, 500 and 1000 were tested. After 24 h of incubation at 37°C, 5% CO 2 , the vector-containing medium was removed and fresh vector-free D10 was added. After 3-4 days cells were collected and fixed in 1% paraformaldehyde in PBS (−). The fraction of cells expressing eGFP was quantified by fluorescent-activated cell sorting (FACS
To determine the extent of transduction of the lentivirus into the corneal tissue, maintained in situ, sections of the cornea embedded in OCT were prepared 1 week after exposure of the tissue to viral particles. Corneal sections were examined by light (Figure 5a ) and fluorescent microscopy ( Figure 5b ). Efficient in situ transduction and eGFP expression in the epithelial layer was observed. While mitotically inactive stromal cells at the exposed cut edge of the corneal button were eGFP positive, unexposed stromal cells located between Descemet's and Bowman's membrane, showed less eGFP expression, implying that virus-cell contact is necessary for transduction (data not shown). We have demonstrated that replication-defective lentiviral vectors are able to transduce mitotically active human keratocytes in vitro, as well as mitotically inactive human corneal tissue in situ. Epithelial cells, endothelial cells and exposed keratocytes are readily transduced and transgene expression is long-lived. Efficient transduction with lentiviral vectors is nontoxic to cells and viral transduction with an eGFP gene does not appear to confer a growth advantage or disadvantage to cells. The success of this lentivirus-mediated transfer of a reporter gene into these cells shows great promise for future applications of this technique in corneal transplant procedures and the treatment of a wide variety of corneal disorders.
Adenoviral vectors have been used to transduce human corneal and animal tissues, however, gene expression is transient. [1] [2] [3] [4] Adenovirus-mediated transgene expression within human corneas in situ was maintained at high levels for only 7 days, with expression diminishing to undetectable levels by 28 days.
1 Similar
Gene Therapy results were obtained for adenoviral gene transfer to rabbit and rat corneas ex vivo, where the level of lacZ marker gene expression decreased after obtaining a peak expression level at 3-7 days after transduction. 2 In this study, we have shown that lentivirus-mediated transduction is efficient and stable. Undiminished eGFP gene expression is observed up to 60 days for human keratocytes in vitro and human corneal tissue in situ, respectively.
The inhibition of adenoviral entry into the deep layers of corneal stroma has been attributed to barrier functions of Descemet's and Bowman's membranes. 2 Our observation of a marked absence of eGFP expression in deep corneal stromal cells in situ (cells not in direct contact with the virus-containing medium) suggests that the endothelial cells, Descemet's membrane, epithelial cells and Bowman's membrane, individually or in concert, create barriers to viral infection and subsequent transduction. Since primary keratocytes in culture were transduced efficiently, and stromal cells at the exposed cut edge of the corneal button were positive for eGFP, it is likely that viral-cell contact is required for efficient gene transfer with both vectoring systems.
We have demonstrated by Southern analysis of genomic DNA isolated from cells transduced with this lentiviral vector, integration of the lentiviral-eGFP vector into the host genome (data not shown). Expression of the eGFP gene from an integrated lentiviral vector appears to confer no selective advantage for or against transduced cells. As an integrative vector, transduced cells are able to transmit the transgene to progeny cells. It is possible that the lack of genomic integration is responsible for the ephemeral nature of expression of adenoviral or liposomal transgenes. The integrative ability of the lentiviral vector raises the possibility of indefinite expression of a therapeutic transgene by targeting corneal stem cells, situated at the corneal limbus. 23 Although, Qavi et al 24 demonstrated that HIV-1 can infect corneal epithelial cells in vitro, this is the first report of a HIV-1-derived lentiviral vector conferring efficient transduction into human corneal epithelial and endothelial cells in situ.
In conclusion, the results of this study indicate that a replication-defective lentiviral vector is able to transfer efficiently transgenes to human corneal endothelial and epithelial cells in situ and keratocytes in vitro, and achieve long-term transgene expression. This vector may be useful in the treatment of corneal epithelial or endothelial disorders and may be applied to modify the genetic makeup of a donor cornea tissue ex vivo, before transplantation, in such a way as to modulate permanently the process of allograft rejection.
